Design-for-Six-Sigma To Develop a Bioprocess Knowledge Management Framework

References

1. 1.↵
   1. Hill C.,
   2. Sinclair A.

   Process development: maximizing process data from development to manufacturing. July 2007. http://biopharminternational.findpharma.com/biopharm/Article/Process-Development-Maximizing-Process-Data-from-D/ArticleStandard/Article/detail/439424
2. 2.↵
   1. DiMasi J. A.,
   2. Grabowski H. G.

   R&D costs and returns by therapeutic category. Drug Information Journal 2004, 38 (3), 211– 223.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Walzer M.

   Making the leap from research and development to manufacturing. Chemical Engineering 2009, 116 (12), 44– 46.

   OpenUrl
4. 4.↵
   1. Jaluria P.,
   2. Adams D. N.

   Importance of technical operations: lessons from evolving biotherapeutics production methods. Trends in Biotechnol. 2009, 27 (11), 612– 614.

   OpenUrl
5. 5.↵
   1. Neway J.

   How the data ecosystem affects process development and the bottom line. BioProcess Int. 2004, 2, 82– 91.

   OpenUrl
6. 6.↵
   1. Hans J.,
   2. Bansal A.

   Biopharmaceutical information 2.0. Part 1 of 2. BioProcess Int. 2009, 7 (11), 10– 19.

   OpenUrl
7. 7.↵
   1. Dweck R.

   Knowledge management: is the hype justified? Bio-IT World 2003, 2 (1), 28.

   OpenUrl
8. 8.↵
   1. Gunasekaran A.,
   2. Ngai E. W. T.

   Knowledge management in 21st century manufacturing. Int. J. Production Res. 2007, 45 (11), 2391– 2418.

   OpenUrl
9. 9.↵
   1. Lai H.,
   2. Chu T. H.

   Knowledge management: a review of industrial cases. J. Comput. Inform. Syst. 2002, 42 (5), 26– 39.

   OpenUrl
10. 10.↵
    1. Pfeffer J.,
    2. Sutton R. I.

    Treat your organization as a prototype: the essence of evidence-based management. Design Management Rev. 2006, 17 (3), 10– 14, 80– 81.

    OpenUrl
11. 11.↵
    International Conference on Harmonization. Q10. Pharmaceutical Quality System. Portland, Oregon, 2008.
12. 12.↵
    1. Darroch J.

    Developing a measure of knowledge management behaviors and practices. J. Knowledge Management 2003, 7 (5), 41– 54.

    OpenUrl
13. 13.↵
    1. Powell W. W.

    Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries. California Management Rev. 1998, 40 (3), 228– 240.

    OpenUrl
14. 14.↵
    1. Somma R.

    Development knowledge can increase manufacturing capability and facilitate quality by design. J. Pharma. Innov. 2007, 2 (3–4), 87– 92.

    OpenUrl
15. 15.↵
    1. Sapienza A. M.,
    2. Lombardino J. G.

    Recognizing, appreciating, and capturing the tacit knowledge of R&D scientists. Drug Dev. Res. 2002, 57 (2), 51– 57.

    OpenUrl
16. 16.↵
    1. Meso P.,
    2. Smith R.

    A resource-based view of organizational knowledge management systems. J. Knowledge Management 2000, 4 (3), 224– 234.

    OpenUrl
17. 17.↵
    1. Zucker L.,
    2. Darby M. R.,
    3. Armstrong J. S.

    Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology. Management Science 2002, 48 (1), 138– 153.

    OpenUrlCrossRefWeb of Science
18. 18.↵
    1. Beardsley S.,
    2. Johnson B. C.,
    3. Manyika J. M.

    Competitive advantage from better interactions. The McKinsey Quarterly 2006, 2, 53– 63.

    OpenUrl
19. 19.↵
    International Conference on Harmonization. Q8R2. Pharmaceutical development. Step 4 version. Geneva, Switzerland, 2009.
20. 20.↵
    Process validation: general principles and practices. Guidance for Industry, United States Food and Drug Administration, 2011.
21. 21.↵
    1. Pentland A.

    How social networks network best. Harvard Business Review 2009, 87 (2), 37.

    OpenUrlPubMed
22. 22.↵
    1. Siddiqui A.

    Using Web 2.0 tools to increase your productivity. Chemical Engineering 2009, 116 (3), 31– 32.

    OpenUrl
23. 23.↵
    1. Anand P.,
    2. Cox J.

    The cloud can take biopharmaceutical outsourcing to new heights. BioProcess Int. 2009, 7 (9), 20– 25.

    OpenUrl
24. 24.↵
    1. Sansom C.

    Gathering clouds and a sequencing storm. Nature Biotechnol. 2010, 28 (1), 1, 13– 15.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Neway J.

    Software simplifies accounting for batch genealogy. BioProcess Int. 2009, 7 (7), 32– 35.

    OpenUrl
26. 26.↵
    1. Ilube T.

    What you need to know about the semantic web. Harvard Business Review 2009, 87 (2), 36.

    OpenUrlPubMed
27. 27.↵
    1. Russell J.

    Novartis' answer to Harry Potter. Bio-IT World 2007, 5 (10), 24– 25.

    OpenUrl
28. 28.↵
    1. Salamone S.

    Get serious about information mining. Bio-IT World 2006, 5 (4), 31– 32.

    OpenUrl
29. 29.↵
    1. Studt T.

    Knowledge management is key to improving drug R&D cycles. R&D Magazine 2003, 45 (4), 18.

    OpenUrl
30. 30.↵
    1. Pall G. S.,
    2. McGrath R. G.

    Institutional memory goes digital. Harvard Business Review 2009, 87 (2), 27.

    OpenUrl
31. 31.↵
    1. Cutting-Decelle A. F.,
    2. Young R. I. M.,
    3. Michel J. J.,
    4. Grangel R.,
    5. Le Cardinal J.,
    6. Bourey J. P.

    ISO 15531 MANDATE: a product-process-resource based approach for managing modularity in production management. Concurrent Engineering: Research and Applications 2007, 15 (2), 217– 235.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Forgione P.

    Data management in the supply chain. BioProcess Int. 2008, 6 (10), 20– 26.

    OpenUrl
33. 33.↵
    1. Soliman F.,
    2. Youssef M.

    The role of critical information in enterprise knowledge management. Industrial Management and Data Systems 2003, 103 (7), 484– 490.

    OpenUrl
34. 34.↵
    1. Lee T. S.

    How process development (PD) can support product development optimization. American Pharmaceutical Review 2006, 9 (1), 110– 114.

    OpenUrl
35. 35.↵
    1. Vestal W.

    Knowledge Mapping: The Essentials for Success. APQC Publications: Houston, TX, 2005.
36. 36.↵
    1. DeLong D. W.

    Lost Knowledge: Confronting the Threat of an Aging Workforce; Oxford University Press: Oxford, 2004; pp 92– 94.
37. 37.↵
    1. Hans J.,
    2. Bansal A.

    Biopharmaceutical information 2.0. Part 2 of 2. BioProcess Int. 2010, 8 (2), 10– 15.

    OpenUrl
38. 38.↵
    1. Cross R.

    The Hidden Power of Social Networks: Understanding How Work Really Gets Done in Organization; Harvard Business School Press: Boston, MA, 2004; pp 143– 146.
39. 39.↵
    1. McCann J. E.,
    2. Buckner M.

    Strategically integrating knowledge management initiatives. J. Knowledge Management 2004, 8 (1), 47– 63.

    OpenUrl
40. 40.↵
    1. Von Geibler J.,
    2. Liedtke C.,
    3. Wallbaum H.,
    4. Schaller S.

    Accounting for the social dimension of sustainability: experiences from the biotechnology industry. Business Strategy and the Environment 2006, 15 (5), 334– 346.

    OpenUrlCrossRef
41. 41.↵
    1. Palacios-Marques D.,
    2. Garrigos-Simon F. J.

    A measurement scale for knowledge management in the biotechnology and telecommunications industries. Int. J. Technol. Management 2005, 31 (3–4), 358– 374.

    OpenUrl
42. 42.↵
    1. Muscatello J. R.

    The potential use of knowledge management for training. Business Process Management Journal 2003, 9 (3), 382– 394.

    OpenUrl
43. 43.↵
    1. Henard D. H.,
    2. McFadyen M. A.

    Making knowledge workers more creative. Research Technology Management 2008, 51 (2), 40– 46.

    OpenUrl
44. 44.↵
    1. Hodgson J.

    The headache of knowledge management. Nature Biotechnology 2001, 19 (Suppl.), 44– 46.

    OpenUrl
45. 45.↵
    1. Proffitt A.

    AstraZeneca invests in data, discovery management. Bio-IT World 2008, 7 (6). http://www.bio-itworld.com/issues/2008/july-august/best-practices-astrazeneca.html
46. 46.↵
    1. Montague G.,
    2. Martin E.

    From data to knowledge: the challenge in bioprocess development. Pharmaceutical Technology Europe 2007. At PharmTech.com. http://www.ptemag.com/pharmtecheurope/IT/From-data-to-knowledge-the-challenge-in-bioprocess/ArticleStandard/Article/detail/456156.